Connect with us

Headlines of The Day

Tata MD receives order for 5L Omicron detection kits from Odisha govt

Tata Group’s medical arm, Tata Medical and Diagnostics Ltd. (Tata MD) has bagged an order for 5 lakh tests from the Odisha State Medical Corporation Ltd (OSMCL), the company said on Monday. The Government of Odisha, hence, has become the first state in the country to order the Tata MD CHECK OmiSure RT- PCR tests, which have been developed in partnership with Indian Council of Medical Research (ICMR), made specifically for detection of the Omicron variant of COVID-19.

Over 14 Omicron cases were detected in Odisha on Saturday, taking the state’s tally to 75. Odisha has so far reported one death due to Omicron. The kits would be procured by OSMCL, an independent procurement agency for the Department of Health and Family Welfare, Government of Odisha. “OmiSure is the only test that can specifically detect the Omicron variant at the point of testing. Odisha is the first state in the country that has decided to use TATA MD OmiSure for COVID testing and would provide all necessary support,” said Girish Krishnamurthy, CEO and Managing Director, Tata Medical and Diagnostics.

Tata MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant. It targets 3 gene with a single tube, fully multiplexed assay in a unique design that identifies simultaneous S-gene Target Failure (SGTF) and S-Gene Mutation Amplification (SGMA). Its confirmatory evaluation of RdRP target with internal controls leads to accurate diagnosis with significant reduction in the risk of false-positive reactions from contamination in control materials. OmiSure uses the standard qPCR workflow, compatible with commonly used qPCR platforms with 4+ channels. Business Today

Copyright © 2024 Medical Buyer

error: Content is protected !!